Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance A. Gil-Núñez; J. Masjuan; J. Montaner; M. Castellanos; T. Segura; P. Cardona; J.I. Tembl; F. Purroy; J. Arenillas; E. Palacio;

Characteristics of stroke units and stroke teams in Spain in 2018. Pre2Ictus project M. Alonso de Leciñana; A. Morales; M. Martínez-Zabaleta; Ó. Ayo-Martín; L. Lizán; M. Castellanos;

Impact of the COVID-19 pandemic on the organisation of stroke care. Madrid Stroke Care Plan B. Fuentes; M. Alonso de Leciñana; P. Calleja-Castaño; J. Carneado-Ruiz; J. Egido-Herrero; A. Gil-Núñez; J. Masjuán-Vallejo; J. Vivancos-Mora; J. Rodríguez-Pardo; N. Riera-López; Á. Ximénez-Carrillo; A. Cruz-Culebras; C. Gómez-Escalonilla; E. Díez-Tejedor;